mii-exa-medikation-medication-statement-offset - MII IG Medikation v2027.0.0-ballot

MII IG Medikation
2027.0.0-ballot - Germany

This page is part of the MII Implementation Guide MII IG Medikation (v2027.0.0-ballot: 2027 Ballot 2) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions

Example MedicationStatement: mii-exa-medikation-medication-statement-offset

English

Profile: MII PR Medikation MedicationStatement version: 2027.0.0-ballot

Security Label: test health data (Details: ActReason code HTEST = 'test health data')

status: Active

medication: L-Thyroxin Henning 125 50 Tbl. N2

subject: Max Mustermann Male, DoB: 1965-03-14 ( https://www.medizininformatik-initiative.de/fhir/core/modul-medikation/sid/patient#12345)

effective: 2020-05-27 17:57:00+0100

dosage
timing: 30min , before breakfast, Once per 1 day
route: Oral use
DoseAndRates
- Dose[x]
* 125 Mikrogramm (Details: UCUM codeug = 'ug')

IG © 2019+ NUM-DIZ. Package de.medizininformatikinitiative.kerndatensatz.medikation#2027.0.0-ballot based on FHIR 4.0.1. Generated 2026-09-11
Links: Table of Contents | QA Report | netzwerk-universitaetsmedizin.de | medizininformatik-initiative.de | Legal notice
HL7®, FHIR® and the FHIR flame design are registered trademarks of Health Level Seven International. Their use does not constitute endorsement by HL7.